臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationStatement: 近視的用藥聲明資料

近視的用藥聲明資料

用藥聲明的狀態:Active ( Medication Status Codes#active)

用藥聲明的分類: Outpatient ( MedicationDispense Category Codes#outpatient)

藥品:每瞳令-普益點眼液 ( 臺灣食藥署藥品許可證#衛署藥輸字第005728號)

病人Patient/pat-example "陳加玲"

用藥的日期與時間:2023-11-05T08:00:00

提出聲明日期與時間:2023-11-05T10:00:00

聲明原因:近視(Simple myopia) ( SNOMED CT#232133000)

藥品使用方式:

使用時間:每日使用2次
方式:眼用(Ophthalmic use) ( SNOMED CT#54485002)
備註:每日2次,每次1滴或1-2滴。